Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Valvular Atrial Fibrillation (NVAF)”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Not applicableStudy completedNCT02690155
What this trial is testing

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Who this might be right for
Atrial Fibrillation
Bayer 38,831
Post-approval studies (Phase 4)UnknownNCT03234114
What this trial is testing

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Who this might be right for
Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital with Nanjing Medical University 3,746
Early research (Phase 1)Active Not RecruitingNCT06725355
What this trial is testing

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
HK inno.N Corporation 60
Not applicableActive Not RecruitingNCT05560204
What this trial is testing

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

Who this might be right for
Combined Pulsed-field Ablation (PFA)
Prince of Wales Hospital, Shatin, Hong Kong 200
Not applicableNot Yet RecruitingNCT06969118
What this trial is testing

RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients

Who this might be right for
Atrial FibrillationLeft Atrial Appendage OcclusionGeneral Anesthesia+1 more
Shanghai Zhongshan Hospital 200
Not applicableLooking for participantsNCT04298723
What this trial is testing

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Jena University Hospital 530
Not applicableStudy completedNCT03189069
What this trial is testing

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 36,000
Not applicableStudy completedNCT02951039
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 3,008
Not applicableStudy completedNCT02043808
What this trial is testing

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 25,586
Not applicableNot Yet RecruitingNCT07616414
What this trial is testing

Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)ThromboembolismCardiac Implantable Electronic Device+2 more
Fu Wai Hospital, Beijing, China 424
Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableUnknownNCT06058130
What this trial is testing

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis

Who this might be right for
Acute Ischemic StrokeAtrial FibrillationStenosis, Carotid+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,171
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableStudy completedNCT05438888
What this trial is testing

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 77,814
Not applicableLooking for participantsNCT05204212
What this trial is testing

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent
Prof. Dr. med. Ingo Eitel 430
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Next Page